Results 81 to 90 of about 21,646 (232)

Bioresorbable Scaffolds for Coronary Arteries: Where Do We Stand Today?

VIEW Medicine, Volume 1, Issue 1, August 2026.
Bioresorbable coronary scaffolds are moving from thick strut pitfalls to thinner, stronger, healing‐oriented designs. Integrating advances in materials, guided implantation with preparation, size, and postdilation steps, and resorption aligned to healing, we synthesize clinical evidence and chart a roadmap toward intelligent, transient platforms ...
Junya Matsuda, Tatsuya Watanabe, Satoshi Yuhara, John M. Kelly, Hirotsugu Kurobe, Toshiharu Shinoka   +5 more
wiley   +1 more source

Interstitial pneumonia caused by dabigatran

, 2018
We describe the case of a 73-year-old man who experienced dry cough and exertional dyspnea after dabigatran administration. Chest radiographs revealed the development of bilateral consolidative and ground glass opacity, and transbronchial lung biopsy ...
Norio Yamamoto, Naoki Hamada, Eiji Harada, Yasuaki Kotetsu, Toyoshi Yanagihara, Yoshinao Oda, Kunihiro Suzuki, Yoichi Nakanishi, Kayo Ijichi   +8 more
core   +1 more source

Secondary Analysis: Odds of Switching to Dabigatran after ODBP listing of Dabigatran–Adjusted Model.

, 2016
Secondary Analysis: Odds of Switching to Dabigatran after ODBP listing of Dabigatran–Adjusted Model.
Michelle Sholzberg (2513476), David N. Juurlink (259072), Tara Gomes (563908), Zhan Yao (2513473), Andreas Laupacis (39520), Muhammad M. Mamdani (259064)   +5 more
core   +1 more source

Dabigatran-induced esophagitis

Cleveland Clinic Journal of Medicine, 2019
The tablets contain tartaric acid, and if they get stuck in the esophagus, the acid leaching out can damage the mucosa.
openaire   +2 more sources

Therapeutic potential of small molecules that block receptor‐induced Kv7/M‐current suppression in neuroprotection, seizures, and pain

British Journal of Pharmacology, Volume 183, Issue 13, Page 3780-3795, July 2026.
Receptor‐induced Kv7/M‐current suppression increases neuronal activity and contributes to pathology of several conditions. A new class of Kv7 modulators identified in this study attenuates M‐current suppression and shows therapeutic effects. Abstract Background and Purpose Neuronal Kv7 channels generate low voltage–gated potassium currents known as the
Young Woo Kim, Pavan Kumar Behara, Lamees Alhassen, Cindy Wong, Olivier Civelli, Naoto Hoshi   +5 more
wiley   +1 more source

Primary Analysis: Odds of Switching to Dabigatran Prior to ODBP listing of Dabigatran–Adjusted Model.

, 2016
Primary Analysis: Odds of Switching to Dabigatran Prior to ODBP listing of Dabigatran–Adjusted Model.
Michelle Sholzberg (2513476), David N. Juurlink (259072), Tara Gomes (563908), Zhan Yao (2513473), Andreas Laupacis (39520), Muhammad M. Mamdani (259064)   +5 more
core   +1 more source

Dabigatran etexilate for secondary stroke prevention: the first year experience from a multicenter short-term registry

Therapeutic Advances in Neurological Disorders, 2014
Background: There are growing concerns for the side effects of dabigatran etexilate (dabigatran), including higher incidence of dyspepsia and gastrointestinal bleeding.
Georgios Tsivgoulis, Christos Krogias, Kara A. Sands, Vijay K. Sharma, Aristeidis H. Katsanos, Konstantinos Vadikolias, Sokratis G. Papageorgiou, Ioannis Heliopoulos, Harn Shiue, Athina Mitsoglou, Chrissoula Liantinioti, Dimitrios Athanasiadis, Sotirios Giannopoulos, Charitomeni Piperidou, Konstantinos Voumvourakis, Andrei V. Alexandrov   +15 more
doaj   +1 more source

Cost-effectiveness of dabigatran versus genotype-guided management of warfarin therapy for stroke prevention in patients with atrial fibrillation.

PLoS ONE, 2012
BackgroundDabigatran is associated with lower rate of stroke comparing to warfarin when anticoagulation control is sub-optimal. Genotype-guided warfarin dosing and management may improve patient-time in target range (TTR) and therefore affect the cost ...
Joyce H S You, Kia K N Tsui, Raymond S M Wong, Gergory Cheng   +3 more
doaj   +1 more source

Dabigatran and apolipoprotein B [PDF]

Heart, 2015
Dabigatran is the first of a series of new direct acting oral anticoagulants that was clinically introduced for the prevention of ischaemic stroke in patients with atrial fibrillation (AF). In the randomized evaluation of long-term anticoagulation therapy (RE-LY) study, dabigatran was shown to be superior or non-inferior to warfarin in preventing ...
openaire   +2 more sources

Association of SGLT2 Inhibitor With Stroke in Type 2 Diabetes With Diabetic Retinopathy: A Multicenter Electronic Health Record Data Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 7, Page 5614-5626, July 2026.
ABSTRACT Aims Diabetic retinopathy (DR) is linked to elevated risks of cerebrovascular diseases. Whether sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) reduce stroke risk in patients with type 2 diabetes (T2D) and DR remains uncertain. Materials and Methods We conducted a retrospective cohort study using the TriNetX Research Network.
Kuo‐En Chen, Po‐Chun Wang, Hui‐An Lin, Sheng‐Feng Lin   +3 more
wiley   +1 more source